(Total Views: 699)
Posted On: 05/27/2021 8:21:22 AM
Post# of 148892
I would normally agree with you, but in this case I welcome this PR as it sheds a bit of light on our partner's sentiment following the bizarre release from the FDA last week.
It signals to the market that Biomm could give 2 craps about the FDA's need to be the sole arbiter of pharmacological truth. Biomm continues to see the potential in Leronlimab and is moving forward!
It signals to the market that Biomm could give 2 craps about the FDA's need to be the sole arbiter of pharmacological truth. Biomm continues to see the potential in Leronlimab and is moving forward!
(25)
(0)Scroll down for more posts ▼
